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a  b  s  t  r  a  c  t
The  species  Maytenus  guyanensis  Klotzsch  ex  Reissek,  Celastraceae,  present  a wide  variety  of possible
pharmacological  activities  and  its  roots  and  stems  are  used  by  popular  medicine  in  the  western  Amazon
rainforest.  Few  studies  have  demonstrated  the  genotoxic  safety  of the  popular  use of  this  species,  and
owing  to this,  the  present  study  aimed  to  perform  an analysis  of  the acute  genotoxicity  in  vivo  of the
aqueous  extract  of  M.  guyanensis.  Male  and  female  mice  from  Mus  musculus  species,  of weights  ranging
from  20  to 40  g,  organized  in  eight  groups  with  different  treatments  were  used.  The  aqueous  extracts  of  the
bark of  M.  guyanensis  were  administered  orally  by  gavage  with  0.1  ml  of  the test  substance  per  10  g  of the
animal,  followed  by performance  of  comet  assay  in  peripheral  blood,  PCE/NCE  correlation  and  occurrence
of  micronuclei  in  the  bone  marrow.  It was  found  that  the  aqueous  extract of  M. guyanensis,  with ten
times  higher  concentration  than  those  used  in  ethnopharmacology,  did not  present  genotoxic  effect  and,
moreover,  it has  antigenotoxic  action  in  mice  treated  acutely.  Further  studies  regarding  bioaccumulation
and  chronic  effects  of this  species  are  suggested,  in  order  to improve  the understanding  of  its mechanism
of  action,  ensuring  the  efﬁcacy  and  safety  of its utilization  and developing  phytotherapics  and  drugs.
©  2015  Sociedade  Brasileira  de  Farmacognosia.  Published  by  Elsevier  Editora  Ltda.  All  rights  reserved.ntroduction
Brazil possesses almost 19% of the world’s ﬂora, of which the
mazon Forest is one of the most rich and diversiﬁed area on the
lanet; however, roughly 99% of the medicinal plants do not have
ts efﬁcacy and pharmacological safety proven (Giulietti et al., 2005;
ão et al., 2012; Meneguetti et al., 2014), making necessary a phy-
ochemical and pharmacological approach (Andrade et al., 2007),
hich may  represent a great economic potential to be explored
y the pharmaceutical industry (Cechinel-Filho and Rosendo,
998).
∗ Corresponding author.
E-mail: dionatas@icbusp.org (D.U.d.O. Meneguetti).
http://dx.doi.org/10.1016/j.bjp.2015.03.003
102-695X/© 2015 Sociedade Brasileira de Farmacognosia. Published by Elsevier EditoraThe popular medicinal species Maytenus guyanensis Klotzsch
ex Reissek belongs to Celastraceae botanical family and is a small
endemic tree, popularly known as “chichuá”, “xixuá”, “chuchauasi”,
“chuchuhuashu”, “chuchuasi”, “chuchasa” or “tonipulmon”
(Revilla, 2001; Prata, 2007; Prata and Mendonca, 2009). The
species present a wide variety of possible pharmacological activi-
ties, wherein its roots and stems are used popularly as analgesic,
muscle relaxant, wound healing, insecticide, immunosuppressive,
anti-inﬂammatory, anti-ulcerogenic, anti-rheumatism, anti-
diarrheal, antibacterial, antifungal, anti-helminthic, antiprotozoal,
antitumor, aphrodisiac and gynecologically active (Revilla, 2002;
Borrás, 2003; Macari et al., 2006; Fonseca et al., 2007).Phytochemical studies of species from the genus Maytenus have
demonstrated presence of several chemical groups, in which we
can contrast the quinone-methide triterpenoids that presented
several biological activities, such as tripanocide (Duarte et al.,
 Ltda. All rights reserved.
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002), anti-helminthic (Mena-Rejón et al., 2007), cytotoxic and
ntitumor (Morita et al., 2008). Other metabolites identiﬁed within
his genus were: tannins, ﬂavonoids and alkaloids (Santos-Oliveira
t al., 2009; Gonzalez et al., 1996; Chavez et al., 1998).
Phytochemical studies of leaves, stem barks and roots of M.
uyanensis lead to isolation and identiﬁcation of ten terpenoids,
herein ﬁve are friedelane: friedeline, friedelol, 16-friedeline,
9-hydroxifriedeline and 3,7-friedelodione; one of them is a -
merine oleanane; one of them is a -amerine ursane, and three are
riedo-nor-oleanane (quinine-methides): tingenone, 22-hydroxy-
ingenone and 22-hidroxi-pristimerine. In addition, two  steroids:
-sitosterol and sitostenone, one sesquiterpene alkaloid named
,N-dimethylserine (Sousa et al., 1986; Facundo et al., 2015) and
ne ﬂavonoid: 4-methyl-epigalocatequine (Macari et al., 2004)
ere also identiﬁed; however, few studies have demonstrated the
enotoxic safety of the popular use of this species, and owing to
t, the present study aimed to perform an analysis of the acute
enotoxicity in vivo of the aqueous extract of M. guyanensis.
aterials and methods
ollection and identiﬁcation of botanical material
The barks of Maytenus guyanensis Klotzsch ex Reissek, Celas-
raceae, were collected in February 2008 at the Adolpho Ducke’s
orest Reserve, located at the km 26, AM-010 road (Manaus-
tacoatiara – Lat 02◦53′ S, Long 59◦58′ W).  The identiﬁcation of the
pecies was done at the Herbário do Instituto Nacional de Pesquisa
a Amazônia (INPA), Exsiccate n◦ 188.485.
xtract preparation
Barks from M.  guyanensis were grinded to improve solvent con-
act area. The extract was prepared by infusion with distilled water
or 10 min  at 80 ◦C, at the following concentrations: 3.85 mg/ml,
alue normally used by populations and ten, twenty and ﬁfty
imes more concentrated (Camparoto et al., 2002; Meneguetti et al.,
014).
nimals’ treatment
The tests were performed from January to March 2014, at Lab-
ratory de Genetic e Toxicology Applied from Centro academic
utheran de Ji-Paraná (CEULJI/ULBRA), in Ji-Paraná city, Rondônia,
razil. All of the experiments were approved by Ethics Commit-
ee on Animal Use (CEUA) from Oswaldo Cruz Foundation – RO
Fiocruz-RO), protocol number 2013/12.
Mus  musculus’s male and female mice were used, acquired from
EULJI/ULBRA vivarium, with weight ranging from 20 to 40 g. The
queous extracts from barks of M.  guyanensis were administered
ia oral gavage, two amounts at 48 and 24 h, respectively, before
he test began. The animals were weighed before the dosage and
he volume administered was calculated as 0.1 ml  of the testing
ubstance per 10 g of the animal.
The animals were divided into eight groups, each one contain-
ng eight animals, four were male and four female, and they were
aintained in environments with controlled temperature (25 ◦C),
ith cycles of 12 h of light and 12 h of darkness, in polyethylene
ages, with access to water and food.
The following groups were organized as follows:G1 – negative control (CN), where only H2O was administered;
G2 to G5 – treated with aqueous extracts of M.  guyanensis in
concentrations 3.85 mg/ml, 38.5 mg/ml, 77 mg/ml  and 192 mg/ml,
respectively;de Farmacognosia 25 (2015) 164–169 165
G6 and G7 – treated, respectively, with 3.85 mg/ml and
38.5 mg/ml, with addition of 2.0 mg  cyclophosphamide per 100 g
of animal weight, treated via intraperitoneal injection, 24 h before
the application of the ﬁrst dose of the aqueous extract of M.  guya-
nensis. These concentrations were chosen, based on a study carried
out by Meneguetti et al. (2014), in which these same concentra-
tions presented anticytotoxic and anti-mutagenic action in in vitro
studies;
G8 – positive control (CP), just 2.0 mg  of cyclophosphamide was
administered per 100 g of mice weight (Magalhães et al., 2010), via
intraperitoneal injection, 24 h before the application of the ﬁrst
dose of the aqueous extract of M.  guyanensis,  being also treated
with 0.1 ml  of H2O per 10 g of the animal, via gavage, at the same
periods as too much groups.
Comet assay
The genotoxicity and acute antigenotoxicity analysis were done
by comet assay, from the method described by Singh et al. (1988)
and reviewed by Tice et al. (2000). The experiment was performed
in blood cells from the animals submitted to the treatment with the
aqueous extract of M. guyanensis. The peripheral blood of animals
was collected after the decapitation with a guillotine, wherein two
slides per animal were prepared.
The samples in cellular suspension were mixed with a thin layer
of agar “low melting” 0.75% and laid upon layers pre-covered with
normal agarose at 1.5%. These slides were plunged in a lysis solution
(2.5 M NaCl, 100 mM EDTA and 10 mM Tris, pH 10 with addition of
1% Triton X-100 and 10% DMSO at the time of use), for 96 h at 4 ◦C.
The lysis enables the migration of the DNA fragments that were
brought about after incubation of the slides in alkaline tampon
(300 mM NaOH and 1 mM EDTA, pH > 13) for 20 min  and, subse-
quently, an electric current of 300 mA  and 25 V (0.90 V/cm) was
applied for 15 min  in a DNA electrophoresis vat. The slides were
neutralized after electrophoresis with three tampons at 0.4 M,  pH
7.5 and colored with silver nitrate.
The analysis of the cells was performed randomly by visual
evaluation, totaling 100 cells/slide, wherein two parameters
were considered: Damage Index (0–400) and Damage Frequency
(0–100%).
Correlation PCE/NCE and occurrence of micronuclei in bone
marrow
Phosphate tampon
The solutions A and B were prepared separately. For the solu-
tion A, 27.6 g of anhydride potassium phosphate (KH2PO4) was
added per liter of distilled water. In the solution B was added 35.6 g
of sodium dibasic phosphate (NA2PO4·7H2O) per liter of distilled
water. After, 16.5 ml  of the solution A was added to 46 ml  of the
solution B and 37.5 ml  of distilled water was added, ﬁlling with
100 ml  with the phosphate tampon with pH = 5.8 (Silva et al., 2011).
Bone medulla gathering and preparation of the microscopic slides
After the animals were sacriﬁced by guillotine decapitation, the
femurs were withdrawn, cleaned and the two ends removed with a
surgical scissor. The bone marrow was  extracted with a histological
needle directly upon the slide with 10 l of fetal bovine serum, and
with a curved histological needle the marrow was homogenized
with serum, wherein a smear of each femur was  made, and two
slides per animal were prepared.The slides were dried in an incubator at 37 ◦C, colored with a
mixture of Giemsa (10%) and phosphate tampon (pH = 5.8), washed
with distilled water, dried at room temperature and marked with
a numeric code, for a “blind” analysis. The coloration was used to
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tig. 1. Genotoxic and antigenotoxic acute effects evaluated in damage index and 
reatment with aqueous extract of M.  guyanensis. M:  Males; F: Females; T: Total 
**(p  < 0.001) when compared to CN. Statistically signiﬁcant for antigenotoxicity #(p
ifferentiate light blue polychromatic erythrocytes (PCE) and red
ormochromatic erythrocytes (NCE) (Ribeiro et al., 2003).
nalyses of slides
The zig-zag model was used to determine simultaneously the
mount of micronuclei of each 1000 PCE and the relationship
etween PCE and NCE in 1000 erythroid cells per slide.
This relationship was established to avoid determination of
alse-negatives, demonstrating whether there was  cytotoxicity or
ellular depression (Shahrim et al., 2006). Afterwards, the count of
nly micronuclei in PCE was  continued until the count of 1000 cells.
he count of micronuclei occurred only in PCE, due to its indication
or organisms with acute exposition analysis (Villela et al., 2003),
he same as used in the present study.e frequency by the comet test in peripheral blood of mice, which underwent the
e and Female. Statistically signiﬁcant for genotoxicity *(p < 0.05), **(p < 0.01) and
5), ##(p < 0.01) and ###(p < 0.001) when compared to CP.
Statistical analysis
The variance analysis was  done by the ANOVA test, using
Turkey’s test as a counterproof, affecting the comparison of the
means of different treatments with the control groups. For this
purpose, the software Graph pad Prism 5.0 was used.
Results
Comet assay
The acute genotoxicity results demonstrated by the index
and frequency of damage performed by the comet assay can be
observed in Fig. 1. The 3.85 mg/ml, 38.5 mg/ml and 77 mg/ml con-
centrations did not present genotoxic effects, unlike the 192 mg/ml,
that presented signiﬁcant genotoxicity relative to CN.
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Fig. 2. Mutagenic effect evaluated by the mean of the number of micronuclei in
mice bone marrow cells, subjected to treatment with aqueous extract of M.  guya-
nensis.  M:  Males; F: Females; T: Total – Male and Female. Statistically signiﬁcant for
mutagenicity *(p < 0.05), **(p < 0.01) and ***(p < 0.001) when compared to CN. Sta-D.U.d.O. Meneguetti et al. / Revista Bras
In the analysis of the antigenotoxic potential, 3.85 mg/ml  and
8.5 mg/ml  concentrations demonstrated signiﬁcant decrease in
oth the damage index and the damage frequency relative to the
P group.
orrelation PCE/NCE
The data corresponding to the correlation PCE/NCE inﬂuenced
y the aqueous extract of M.  guyanensis are organized in Table 1.
he correlation PCE/NCE of the 3.85 mg/ml  and 18.5 mg/ml  concen-
rations did not present signiﬁcant difference relative to CN. This
esult was not observed in the 77 mg/ml  and 192 mg/ml  concentra-
ions, that decreased the correlation, demonstrating the occurrence
f cytotoxicity (Shahrim et al., 2006; Silva et al., 2011), that is
ormally conﬁrmed due to the dose-response effect (Krishna and
yashi, 2000) and the likely explanation is that the frequency of cell
epression (Nesslany et al., 2004) can induce to apoptosis (Ouanes
t al., 2003), due to it being subjected to balance regulation between
he activation and suppression of cell death in certain situations
Kaufmann and Hengartner, 2001).
The 3.85 mg/ml  and 38.5 mg/ml  concentrations that did
ot present cytotoxity, also demonstrated anticytotoxic action,
ncreasing the PCE/NCE correlation, signiﬁcantly reversing the
amage caused by cyclophosphamide.
icronuclei in bone marrow
The mean of micronuclei for each 1000 cells of mice bone mar-
ow subjected to treatment with different concentrations of the
queous extract of M.  guyanensis, can be visualized in Fig. 2.
The 3.85 mg/ml, 38.5 mg/ml  and 77 mg/ml concentrations did
ot present mutagenic effects in male and female mice, however,
hen the total mean was assessed, the 77 mg/ml  concentration
howed to be mutagenic relative to CN, which was  also observed
n the 192 mg/ml  concentration in male, female and total mean.
The 3.85 mg/ml  and 38.5 mg/ml  concentrations demonstrated
ntigenotoxic effects again, acting as antimutagenic, decreasing
igniﬁcantly the number of micronuclei relative to CP.
iscussion
The genotoxic safety and antigenotoxic action of 3.85 mg/ml  and
8.5 mg/ml  concentrations of the aqueous extract of M. guyanensis
as already seen in a previous study using Allium cepa, where these
ame concentrations demonstrated anticytotoxic and antimuta-
enic action relative to meristems germination, mitotic indexes
nd micronuclei formation (Meneguetti et al., 2014), being also
n agreement with Hurtado (2013), in which fractions of M. guya-
ensis showed anti-proliferative activity within a wide period of
ime, not presenting clastogenic or aneugenic actions, where this
atter was also observed in a study carried out by Mendes et al.
2012), demonstrating that the ethanolic extract of M.  rigida does
ot induce chromosomal abnormalities.
The antimutagenic action was also observed by Salmonela/
icrosome test (Ames Test) in which the hydroalcoholic extract of
he bark of M.  krukovii presented exhibits inhibitory activity against
he T98 and T100 lines (Bruni et al., 2006).
Previous studies have demonstrated that the quinone-methide
riterpenes are one of the main causes of the antigenotoxic action
ound in some species of the genus Maytenus,  acting in vitro against
umor cells and against experimental tumors, in which the species
aytenus ilicifolia presented inhibitory activities against differentarcomas and neoplastic cells (Santana et al., 1971; Santos-Oliveira
t al., 2009), strengthening the results found in the 3.85 mg/ml  and
8.5 mg/ml  concentrations of the aqueous extract of M. guyanensis,
hat probably occurred due to the presence of quinone-methidetistically signiﬁcant for antigenotoxicity #(p < 0.05), ##(p < 0.01) and ###(p < 0.001)
when compared to CP.
triterpenes identiﬁed previously in this species (Facundo et al.,
2015). Similar results were observed with the tingenone-quinone
methide (maitenine) in vitro tests that demonstrated inhibition of
Leuk-P 138, CA 9KB and V79 neoplastic cell lines (Kupchan and
Karim, 1976).
Studies performed in humans with other triterpenes isolated
from Maytenus ssp. demonstrated the decrease of wounds on the
base of the tongue and pharynx by approximately 50%, caused by
epidermoid carcinomas and 40% of the lymphoepithelioma with
invasion to the orbit, besides positive results in 2 of the 7 patients
with uterine epidermoid carcinoma (Santana et al., 1971).
In another clinical series, the triterpene maitenine “tingenone
analog” (Morita et al., 2008; Gullo et al., 2012; Facundo et al.,
2015), also isolated from the genus Maytenus,  potentiated other
anti-cancerogenic substances of natural sources in eleven patients
with advanced basal-cell carcinoma, in which all of the patients
presented clinical recovery, with reduction of wound size by more
than 50% (Melo et al., 1974; Corsino et al., 2000).The anti-ulcerogenic effects occurred mainly due to the antiox-
idant activities of catequine derivatives found in some species of
the genus Maytenus,  and these derivatives act in a more effective
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Table 1
Mean ± standard deviation of the number of Polychromatic Erythrocytes (PCE), Normochromatic Erythrocytes (NCE) and of the PCE/NCE ratio in mice bone marrow cells,
which  underwent the treatment with aqueous extract of Maytenus guyanensis.
Treatment (mg/ml) Gender N (PCE) (NCE) Correlation (PCE/NCE)
CN Male 4 2571 ± 8.2 2429 ± 8.2 1.06 ± 0.07
Female 4 2616 ± 5.8 2384 ± 5.8 1.10 ± 0.05
Total  8 2594 ± 7.5 2406 ± 7.5 1.08 ± 0.06
CP Male  4 1835 ± 13.6 3165 ± 13.6 0.58 ± 0.07***M
Female 4 1737 ± 4.7 3262 ± 4.7 0.53 ± 0.02***F
Total 8 1786 ± 11.3 3214 ± 11.3 0.56 ± 0.06***T
3.85 Male 4 2622 ± 8.1 2377 ± 8.1 1.10 ± 0.07
Female 4 2581 ± 6.7 2419 ± 6.7 1.07 ± 0.06
Total  8 2602 ± 7.8 2398 ± 7.8 1.08 ± 0.07
38.5 Male  4 2526 ± 5.8 2474 ± 5.8 1.02 ± 0.05
Female 4 2541 ± 7.3 2459 ± 7.3 1.03 ± 0.06
Total  8 2534 ± 6.6 2466 ± 6.6 1.03 ± 0.05
77 Male  4 2362 ± 13.2 2637 ± 13.2 0.90 ± 0.09**M
Female 4 2381 ± 11.3 2619 ± 11.3 0.91 ± 0.08***F
Total 8 2372 ± 12.3 2628 ± 12.3 0.90 ± 0.09***T
192 Male 4 2161 ± 11.2 2839 ± 11.2 0.76 ± 0.07***M
Female 4 2165 ± 9.4 2835 ± 9.4 0.77 ± 0.06***F
Total 8 2163 ± 10.4 2837 ± 10.4 0.76 ± 0.07***T
3.85 + CP Male 4 2155 ± 6.6 2845 ± 6.6 0.76 ± 0.04***M###M
Female 4 2194 ± 7.4 2806 ± 7.4 0.78 ± 0.05***F###F
Total 8 2174 ± 7.3 2826 ± 7.3 0.77 ± 0.04***T###T
38.5 + CP Male 4 2212 ± 8.6 2787 ± 8.6 0.79 ± 0.05***M###M
Female 4 2221 ± 7.9 2779 ± 7.9 0.80 ± 0.05***F###F
Total 8 2217 ± 8.2 2783 ± 8.2 0.80 ± 0.05***T###T
Statistically signiﬁcant for genotoxicity: *M(p < 0.05), **M(p < 0.01) and ***M(p < 0.001) when compared to male CN. *F(p < 0.05), **F(p < 0.01) and ***F(p < 0.001) when com-
p to tota
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##M(p < 0.001) when compared to male CP. #F(p  < 0.05), ##F(p  < 0.01) and ###F(p  < 
ompared to total CP.
ay on the wound of the digestive tract, inhibiting the damage
f mucosa cells by free radicals generated by the very digestive
rocess. This effect is also related to an anti-mutagenic action, pro-
ecting against genotoxic agents that may  induce the malignant
ransformation of the intestinal mucosa cells (Krul et al., 2001).
The antioxidant action was already reported for the species M.
uyanensis (Macari et al., 2006), for M.  procumbens (Momtaz et al.,
013) and for ilicifolia (Macari et al., 2006; Negri et al., 2009) in
hich the lipid peroxidation is inhibited (Santos-Oliveira et al.,
009) and shows chelant activity of heavy metals, besides acting
n different free radicals (Ho et al., 1992; Melo et al., 2001).
In this study, the concentration of 77 mg/ml  of the aqueous
xtract of M.  guyanensis did not present genotoxic action for the
ndex and frequency of damage evaluated by the comet assay, or
or the formation of micronuclei on the bone marrow of male and
emale mice. On the other hand, it presented genotoxic effects in
he total mean of the micronuclei test and also in the ratio PCE/NCE.
he negative results for the concentration of 77 mg/ml  in the comet
ssay might have occurred due to analyses of only the acute effects,
n which further studies are suggested for a better comprehension
f the chronic effects caused by the ingestion of infusions of aque-
us extracts of M.  guyanensis; according to Bode and Dong (2014)
everal natural compounds found in various plants consumed by
raditional population are potential carcinogens or tumor promo-
ers and its use for long periods of time should be avoided.
In the 192 mg/ml  concentration the data demonstrated geno-
oxic effects in all of the tests performed, being in agreement with
 study done by Meneguetti et al. (2014), in which the 77 mg/ml
nd 192 mg/ml  concentrations presented cytotoxic and mutagenic
ctions.
It is important to highlight that 77 mg/ml  and 192 mg/ml
oncentrations are, respectively, twenty- and ﬁfty-fold more con-
entrated than the concentration normally used by the population:
.85 mg/ml  (Camparoto et al., 2002), bringing a certain tranquility
elative to the use of this species in the ethnopharmacology.
This genotoxicity found in high concentrations was not
videnced in other studies using plants of the same genus, in whichl CN. Statistically signiﬁcant for antigenotoxicity: #M(p < 0.05), ##M(p < 0.01) and
 when compared to female CP. #T(p < 0.05), ##T(p < 0.01) and ###T(p < 0.001) when
the chronic toxicology of the infusion of M.  ilicifolia was tested in
rats and mice with doses ranging from 20 to 40 fold higher than
that commonly used by humans, not causing changes in weight,
behavior, temperature and in the biochemical parameters of the
serum and hematological parameters (Carlini and Frochtengarten,
1988).
In other toxicologic studies, this time acute, performed in mice
and rats by infusions and lyophilized extract of M.  ilicifolia, and toxic
effects were not evidenced in doses until 1600-fold higher than the
doses used by humans (Santos-Oliveira et al., 2009).
In human beings, a study of clinical toxicology (Phase I trial),
administered during 14 days, the double of the dosage of M.  ilici-
folia used in ethnopharmacology, did not observe abnormal results
that could be attributed to the plant use. Only symptoms like dry
mouth, nausea, and gastralgia in a few volunteers were recorded,
with recovery during the study, demonstrating thus that M.  ilicifo-
lia is not toxic for humans when used in the same way  as popular
medicine (Carlini and Frochtengarten, 1988).
It was found that aqueous extract of M. guyanensis in con-
centrations up to tenfold higher than the concentration used in
ethnopharmacology does not present genotoxic effects and, more-
over, it has antigenotoxic actions in mice treated acutely. Further
studies of bioaccumulation and chronic effects of this species are
suggested in order to improve the understanding of its action
mechanisms, ensuring the efﬁcacy and safety of its utilization and
development of phytotherapics and drugs.
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